Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Study Type: Interventional"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Study+Type%3A+Interventional%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject&page=5
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Study+Type%3A+Interventional%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject&page=5
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Study+Type%3A+Interventional%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject&page=5
PubPharm (60.420)
41
A placebo controlled Study of Patiromer for the Management of high potassium serum levels in Subjects Receiving a certain group of medications called Renin-Angiotensin-Aldosterone System Inhibitor for treatment of Heart failure. : A Multicenter, Double-blind, Placebo-controlled, Randomized Withdrawal, Parallel Group Study of Patiromer for the Management of Hyperkalemia in Subjects Receiving Renin-Angiotensin-Aldosterone System Inhibitor (RAASi) Medications for the Treatment of Heart Failure (DIAMOND) - DIAMOND
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
42
Investigation of the effect of ondansetron and mirtazapine as treatment for severe nausea and vomiting of pregnancy. : Validating the Effect of Ondansetron and Mirtazapine In Treating Hyperemesis Gravidarum. A Double-blind Randomized Placebo-Controlled Multicentre Trial. - VOMIT
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
43
A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination with Chemotherapy in Patients with HER2-Positive Early Breast Cancer. : A phase III, randomized, multicenter, open-label, two-arm study to evaluate the pharmacokinetics, efficacy, and safety of subcutaneous administration of the fixed-dose combination of pertuzumab and trastuzumab in combination with chemotherapy in patients with HER2-positive early breast cancer.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
44
Effectiveness and Safety of Sparsentan as treatment for Primary Focal Segmental Glomerulosclerosis (FSGS) : A Randomized, Multicenter, Double-blind, Parallel, Active-control Study of the Effects of Sparsentan, a Dual Endothelin Receptor and Angiotensin Receptor Blocker, on Renal Outcomes in Patients with Primary Focal Segmental Glomerulosclerosis (FSGS)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
45
Extended Access of Momelotinib for Subjects with Myelofibrosis : Extended Access of Momelotinib for Subjects with Primary Myelofibrosis (PMF) or Post-polycythemia Vera or Post-essentialThrombocythemia Myelofibrosis (Post-PV/ET MF)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
46
GZ/SAR402671 in Combination with Cerezyme in Adult Patients with Gaucher Disease Type 3 : A 208-week three-part, open-label, multicenter, multinational study of the safety, tolerability, pharmacokinetics, pharmacodynamics, and exploratory efficacy of GZ/SAR402671 in combination with Cerezyme in adult patients with Gaucher disease type 3 - LEAP
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
47
A research study in children born small and who stayed small. Treatment is somapacitan once a week compared to Norditropin® once a day : A dose-finding trial evaluating the effect and safety of once-weekly treatment of somapacitan compared to daily Norditropin® in children with short stature born small for gestational age with no catch-up growth by 2 years of age or older - REAL5
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
48
Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial (ADJUST) : Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial (ADJUST) - ADJUST
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
49
The use of Skilarance® to treat patients with moderate plaque psoriasis : An Open Label, Multi-Center, 24 Week, Exploratory Study to Assess the Efficacy and Safety of Skilarence® (Dimethyl Fumarate) in Patients with Moderate Plaque Psoriasis - M-41008-47 (SMR-3612)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
50
A randomized study to evaluate whether there is a difference in survival between two different forms of anaesthesia. The study will evaluate patients that are scheduled for a surgery for either breast-, colon- or rectalcancer. : A Randomized, Open-label Study to compare Propofol Anaesthesia with Sevoflurane Anaesthesia in terms of Overall Survival in Patients with Surgical Intervention for either Breast-, Colon- or Rectalcancer
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
[1]
« Vorheriger
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[6042]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Study Type: Interventional
Medienart
60.420
Aufsätze
60.420
E-Artikel
60.420
E-Ressourcen
Zeitschriftentitel
60.420
WHO International Clinical Trials Registry Plat...
Thema
60.420
610
60.420
Recruitment Status: Authorised-recruitment may ...
Study Type: Interventional
23.556
Phase: Phase 3
15.068
Phase: Phase 2
4.508
Phase: Phase 4
3.278
Phase: Phase 1
152
Medical Condition: Multiple Myeloma MedDRA vers...
122
Medical Condition: Moderately to Severely Activ...
114
Medical Condition: Diabetes Mellitus, Type 2 Me...
88
Medical Condition: Atopic Dermatitis MedDRA ver...
86
Medical Condition: Ulcerative Colitis MedDRA ve...
86
Medical Condition: Ulcerative Colitis MedDRA ve...
84
Medical Condition: Cystic Fibrosis MedDRA versi...
76
Medical Condition: Asthma MedDRA version: 20.0L...
68
Medical Condition: Myelofibrosis MedDRA version...
66
Medical Condition: Mild cognitive impairment (M...
64
Medical Condition: Chronic Obstructive Pulmonar...
64
Medical Condition: Moderately to Severely Activ...
64
Medical Condition: Multiple myeloma MedDRA vers...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
35.522
2020-
24.898
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
56.722
Englisch
1.244
Unbestimmt
1.058
Französisch
794
Spanisch
162
Finnisch
124
Deutsch
70
Schwedisch
58
Niederländisch
58
Italienisch
44
Dänisch
26
Galizisch
12
Ungarisch
10
Norwegisch
8
Tschechisch
6
Latein
4
Isländisch
2
Estnisch
2
Frisian
2
Hausa
2
Indonesisch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...